Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Return on Capital Employed (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Return on Capital Employed for 12 consecutive years, with 1.09% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Capital Employed fell 57.0% to 1.09% in Q4 2025 year-over-year; TTM through Dec 2025 was 1.09%, a 57.0% decrease, with the full-year FY2025 number at 0.9%, down 39.0% from a year prior.
  • Return on Capital Employed was 1.09% for Q4 2025 at Ekso Bionics Holdings, down from 0.82% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.24% in Q2 2021 to a low of 1.09% in Q4 2025.
  • A 5-year average of 0.55% and a median of 0.55% in 2023 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: skyrocketed 103bps in 2021, then crashed -57bps in 2025.
  • Ekso Bionics Holdings' Return on Capital Employed stood at 0.32% in 2021, then crashed by -57bps to 0.5% in 2022, then crashed by -37bps to 0.69% in 2023, then rose by 26bps to 0.51% in 2024, then plummeted by -112bps to 1.09% in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Return on Capital Employed are 1.09% (Q4 2025), 0.82% (Q3 2025), and 0.66% (Q2 2025).